~~<i id='028E0917A6'><strike id='028E0917A6'><tt id='028E0917A6'><pre id='028E0917A6'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

hotspot

author：focus 2025-09-27 16:35:56 - browse：188

Neumora, a neuroscience startup founded by VC Arch Venture Partners, hopes to become one of the few biotechs to go public this year.

The company filed paperwork for an IPO with the Securities and Exchange Commission on Friday. It did not state how many shares it plans to sell or at what price.

The biotech had begun planning for an IPO last year, STAT reported in June 2022. It raised $112 million in what would turn out to be a crossover round last October.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： 'Ancient DNA,' 23andMe reveal African American ancestries

focus

entertainment

knowledge

hotspot

knowledge

17:55UkrainianPresidentVolodymyrZelenskyyspeakswithABCNews'MarthaRaddatz.YuriyBoyko/ABCNewsKYIV,Ukra

WSS

For BCIs, commercial hurdles may be bigger than scientific ones

Humana, CVS hope to turn members into patients at clinics

Microsoft strikes partnership with Duke Health to advance health AI

Another man arrested in connection with shooting at Kansas nightclub

Another man arrested in connection with shooting at Kansas nightclub

The PBM ad wars are taking over Washington, D.C.

entertainment

hotspot

focus

In Memoriam: Notable people who died in 2023

Attacks on the drug industry will lead to fewer breakthroughs

New air purifier tech could be key to improving indoor air quality

Trump seeks lengthy delay of classified docs trial, citing upcoming election

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

New air purifier tech could be key to improving indoor air quality

OTC birth control: A brief history of over the counter pill design

Psychedelics group wrestles with new pharma identity

What Mike Pence has said that could be used in a Donald Trump trial

entertainment

Submersible on Titanic tour reported missing off Newfoundland with 5 people aboard

What Henrietta Lacks settlement says about racism in medicine

Rare Northern Lights show in US this week: Where and how to see it

Humana, CVS hope to turn members into patients at clinics

'Ancient DNA,' 23andMe reveal African American ancestries

Sen. Bill Cassidy on how to lower drug prices

knowledge

hotspot

knowledge

knowledge